Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
u-STOP LVAD Bleed: ULSCs for LVAD-associated bleeding
NCT04811261Phase 1Completed
- Sponsor
- University of Florida
- Start
- Nov 2021
- Primary completion
- Jul 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of umbilical cord lining stem cells in angiodysplasia, sponsored by University of Florida. Primary endpoint: Dose Limiting Toxicity at 24 hours. Started Nov 2021; status: completed.
02
Drugs
umbilical cord lining stem cells
03
Conditions
angiodysplasia
Beyond the preview
Go deeper on NCT04811261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04811261.